Target
Stromal cell-derived factor-1 alpha
Description
Anti-Stromal Cell-derived Factor-1 alpha Antibody, Non-Fucosylated (BioBet-756ZP) is a human monoclonal IgG antibody against Stromal cell-derived factor-1 alpha. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Autoimmune Diseases; Biliary Cirrhosis, Primary
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Stromal cell-derived factor-1 alpha antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Full Name
chemokine (C-X-C motif) ligand 12
Background
This antimicrobial gene encodes a stromal cell-derived alpha chemokine member of the intercrine family. The encoded protein functions as the ligand for the G-protein coupled receptor, chemokine (C-X-C motif) receptor 4, and plays a role in many diverse cellular functions, including embryogenesis, immune surveillance, inflammation response, tissue homeostasis, and tumor growth and metastasis. Mutations in this gene are associated with resistance to human immunodeficiency virus type 1 infections. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative Names
CXCL12; chemokine (C-X-C motif) ligand 12; IRH; PBSF; SDF1; TLSF; TPAR1; SCYB12; stromal cell-derived factor 1; intercrine reduced in hepatomas; pre-B cell growth-stimulating factor
Cellular Localization
Extracellular region or secreted
Involvement in Disease
Diseases associated with CXCL12 include Human Immunodeficiency Virus Type 1 and Whim Syndrome.
Related Pathways
Its related pathways are Signaling by GPCR and NF-KappaB Family Pathway.
Function
Chemotactic agents are active on T lymphocytes and monocytes, but have no effect on neutrophils. Activating the C-X-C chemokine receptor CXCR4 induces a rapid and short-term increase in intracellular calcium levels and chemotaxis. The chemotactic activity of sdf-1-(3-72) and sdf-1-(3-67) decreased. Binding to cell surface proteoglycans appears to inhibit the formation of sdf-1-(3-67), thereby maintaining activity at local sites. It also binds to the atypical chemokine receptor ACKR3, which activates the -arrestin pathway and acts as a scavenger receptor for SDF-1. Binding to the variable structure site (2 sites) of integrin, activate the integrins ITGAV:ITGB3, ITGA4:ITGB1 and ITGA5:ITGB1 in a cxcr4-independent manner. Through LYN kinase, it plays a positive role in regulating monocyte migration and negatively regulating monocyte adhesion. Stimulates the migration of monocytes and T lymphocytes through their receptors CXCR4 and ACKR3, and reduces the adhesion of monocytes to the surface coated with the -2 integrin ligand ICAM-1. The SDF1A/CXCR4 signal axis inhibits monocyte adhesion to ICAM-1 mediated by integrin-2 integrin LFA-1 through LYN kinase. Inhibit cxcr4-mediated t cell line adaptation to HIV-1 infection. Play a protective role after myocardial infarction. Induce the down-regulation and internalization of ACKR3 expressed by different cells. There are several key functions during embryonic development; it is necessary for b-cell lymphogenesis, bone marrow production and ventricular septum formation. In the presence of IL7, it promotes the proliferation of bone marrow-derived b cell progenitor cells and the growth of stromal cell-dependent pre-b cells (through similarity).
Field of research
Cell Biology and Cellular Response antibody; Immune System antibody; Microbiology and Infectious Disease antibody
Post-translational modifications
Processed forms SDF-1-beta(3-72) and SDF-1-alpha(3-67) are produced after secretion by proteolytic cleavage of isoforms Beta and Alpha, respectively. The N-terminal processing is probably achieved by DPP4. Isoform Alpha is first cleaved at the C-terminus to yield a SDF-1-alpha(1-67) intermediate before being processed at the N-terminus. The C-terminal processing of isoform Alpha is reduced by binding to heparin and, probably, cell surface proteoglycans.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Clone
BioBet-756ZP
Description
The human monoclonal antibody that specifically bind to SDF-1 with high affinity can be used for detecting SDF-1, as well as treating various B cell malignancies, including breast cancer, multiple myeloma and non-Hodgkin's lymphoma, and autoimmune disorders.
Antibody Indication
Autoimmune Diseases; Biliary Cirrhosis, Primary